These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8432460)

  • 41. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flexible sigmoidoscopy: an important screening option for average-risk individuals.
    Levin TR; Palitz AM
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):23-40, vi. PubMed ID: 11916159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recommendations on prevention and screening for colorectal cancer in Hong Kong.
    Lam TH; Wong KH; Chan KK; Chan MC; Chao DV; Cheung AN; Fan CY; Ho J; Hui EP; Lam KO; Law CK; Law WL; Loong HH; Ngan RK; Tsang TH; Wong MC; Yeung RM; Ying AC; Ching R
    Hong Kong Med J; 2018 Oct; 24(5):521-526. PubMed ID: 30318477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoscopic screening for colorectal cancer: recent studies from Indiana University.
    Rex DK
    Indiana Med; 1994; 87(1):68-73. PubMed ID: 8126371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.
    Niv Y; Lev-El M; Fraser G; Abuksis G; Tamir A
    Gut; 2002 Jan; 50(1):33-7. PubMed ID: 11772964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
    Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
    Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
    Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
    J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validity of self-reported colorectal cancer screening behavior.
    Baier M; Calonge N; Cutter G; McClatchey M; Schoentgen S; Hines S; Marcus A; Ahnen D
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):229-32. PubMed ID: 10698488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population.
    Caffarey SM; Broughton CI; Marks CG
    Br J Surg; 1993 Nov; 80(11):1399-400. PubMed ID: 8252347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low compliance with colonoscopic screening in first-degree relatives of patients with large adenomas.
    Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Faivre J; Bonaiti-Pellié C; Bonithon-Kopp C;
    Aliment Pharmacol Ther; 2006 Jul; 24(1):101-9. PubMed ID: 16803608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for large bowel neoplasms in individuals with a family history of colorectal cancer.
    Dunlop MG
    Br J Surg; 1992 Jun; 79(6):488-94. PubMed ID: 1611436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening guidelines for colorectal cancer.
    Kronborg O
    Scand J Gastroenterol Suppl; 1992; 192():123-9. PubMed ID: 1439563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary habits of colorectal neoplasia patients in comparison to their first-degree relatives.
    Kajzrlikova IM; Vitek P; Chalupa J; Dite P
    World J Gastroenterol; 2014 May; 20(17):5025-30. PubMed ID: 24803815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk.
    Taylor DP; Cannon-Albright LA; Sweeney C; Williams MS; Haug PJ; Mitchell JA; Burt RW
    Genet Med; 2011 Aug; 13(8):737-43. PubMed ID: 21555945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Faecal occult blood screening of first degree relatives of patients with colorectal cancer.
    Armitage NC; Farrands PA; Mangham CM; Hardcastle JD
    Int J Colorectal Dis; 1986 Oct; 1(4):248-50. PubMed ID: 3598320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.